MedTrace Logo

Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes

NCT00186004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2011-06-15

No results posted yet for this study

Summary

We wish to find out if in non-diabetic pregnancies, as well as diabetic pregnancies, additional data obtained by Continuous Glucose Monitoring improves perinatal risk prediction.

Conditions

Interventions

DEVICE

Continuous Glucose Monitor

Subjects are fitted with a CGM system and perform self blood glucose measures three or more times per day for 3 days.

Sponsors & Collaborators

  • Santa Clara Valley Health & Hospital System

    collaborator OTHER

  • Stanford University

    lead OTHER

Principal Investigators

  • Yasser Yehia El-Sayed · Stanford University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-12-31
Primary Completion
2006-09-30
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00186004 on ClinicalTrials.gov